The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Does race affect the quality of treatment for intermediate-risk and high-risk prostate cancer?
Nina A. Bickell
Research Funding - Department of Defense
Simon J Hall
No relevant relationships to disclose
Richard Stock
No relevant relationships to disclose
Kezhen Fei
No relevant relationships to disclose
Rajwanth Veluswamy
No relevant relationships to disclose
Rebeca Franco
No relevant relationships to disclose
William K. Oh
No relevant relationships to disclose